Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer (Q24540270)

6 July 2017

title

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer (English)

1 reference

6 July 2017

1 reference

0 references

0 references

12

Lubiński J

1 reference

6 July 2017

2

Byrski T

1 reference

6 July 2017

11

Narod SA

1 reference

6 July 2017

4

Jakubowska A

1 reference

6 July 2017

5

Menkiszak J

1 reference

6 July 2017

6

Gronwald J

1 reference

6 July 2017

3

Huzarski T

1 reference

6 July 2017

1

Górski B

1 reference

6 July 2017

Pluzańska A

7

1 reference

6 July 2017

Bebenek M

series ordinal

8

1 reference

6 July 2017

Fischer-Maliszewska L

series ordinal

9

1 reference

6 July 2017

Grzybowska E

series ordinal

10

1 reference

6 July 2017

language of work or name

English

0 references

publication date

28 April 2000

1 reference

American Journal of Human Genetics

6 July 2017

published in

1 reference

6 July 2017

volume

66

1 reference

6 July 2017

issue

6

1 reference

6 July 2017

page(s)

1963-1968

1 reference

Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Study of a single BRCA2 mutation with high carrier frequency in a small population

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

BRCA1 mutations in Ashkenazi Jewish women

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

DNA sequencing with chain-terminating inhibitors

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Identification of the breast cancer susceptibility gene BRCA2

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Population genetics of BRCA1 and BRCA2.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

A common BRCA1 mutation in Norwegian breast and ovarian cancer families?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Novel BRCA1 mutations and more frequent intron-20 alteration found among 236 women from Western Poland.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancer.

19 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

BRCA1 mutations in primary breast and ovarian carcinomas

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378051

BRCA2 germline mutations in male breast cancer cases and breast cancer families

29 November 2018

1 reference

12 December 2020

Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core

1 reference

12 December 2020

A polymorphic stop codon in BRCA2

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

12 December 2020

Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online

1 reference

12 December 2020

Three per cent of Norwegian Ovarian Cancers are caused by BRCA1 1675delA or 1135insA

1 reference

12 December 2020

Identifiers

DOI

10.1086/302922

1 reference

6 July 2017

1 reference

6 July 2017

1 reference